The University of Oregon announced it will begin offering mifepristone and misoprostol to students on campus this fall, following advocacy efforts by campus groups including UO Students for Choice. The decision makes Oregon among a small number of universities providing direct access to abortion medication.

Meanwhile, Senator Josh Hawley of Missouri has gained additional Republican support for his legislative effort to revoke federal approval of mifepristone, the abortion pill. Three Republican senators have joined Hawley's initiative, though the measure faces significant hurdles in the Democratic-controlled Senate.

The developments come as abortion access remains a contentious issue across multiple policy areas. Mifepristone, approved by the FDA in 2000, is used in combination with misoprostol for medication abortions and has been the subject of ongoing legal and legislative battles.

Separately, new research published in BMJ Global Health suggests that changes in U.S. foreign aid policy correlate with maternal mortality rates in aid-dependent countries. The study indicates that global family planning aid typically decreases under Republican administrations and increases by approximately 48% under Democratic leadership, with researchers linking aid reductions to an 11% increase in pregnancy and childbirth-related deaths in some recipient countries.

The University of Oregon's decision reflects broader efforts by some educational institutions to expand reproductive health services for students, while congressional Republicans continue pursuing federal restrictions on abortion medication access.